EVO
Evotec SE
$2.78
-0.07 (-2.46%)
At close · Jul 8
Market Cap
$987.42M
Shares
355,188,058
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.78
Open$2.79
Day$2.73–2.79
52W$2.31–4.42
Avg vol 30d33K
Short int65K · 0.0% float · 2.1d
Short vol69%
Last earningsMar 31, 2026
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical
Neutral
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−13%
below
Price vs 50-day avg
−3%
below
RSI (14)
49
neutral
MACD trend
Positive
52-week position
22%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−28%
trailing
YTD return
−10%
this year
Relative strength
−36%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -13.4% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Squeeze score
23
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
53%
annualized · 1-yr
Max drawdown
−46%
past year
ATR
3.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−13%
Bearish
Price vs 50-day avg
−3%
Neutral
RSI (14)
49
Neutral
MACD trend
Positive
Bullish
52-week position
22%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Accumulating
+5% holders QoQ · +11 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.02% of float · ▼ -13.4% MoM · 2.1 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
46 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $3 · 22%
52-wk high $4
vs 200-day avg -13%
vs 50-day avg -3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| adjusted EBITDA in D&PD non-GAAP | -9.8M | first quarter 2026 call | — |
| adjusted EBITDA in D&PD at constant exchange rates non-GAAP | -5.5M | first quarter 2026 call | — |
| adjusted EBITDA in the Just-Evotec segment non-GAAP | -12.1M | first quarter 2026 call | — |
| adjusted EBITDA in the Just-Evotec segment at constant exchange rates non-GAAP | -13.4M | first quarter 2026 call | — |
| adjusted group EBITDA non-GAAP | -21.9M | first quarter 2026 call | — |
| adjusted group EBITDA at constant exchange rates non-GAAP | -18.9M | first quarter 2026 call | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
EVO
this stock
Evotec SE
|
$987.42M | -9.7% | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$53.49B | +7.4% | — | — | 0.2% |
|
GALDY
Galderma Group AG/ADR
|
$51.02B | +4.9% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$42.94B | -3.6% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| EVO | -0.7% | -1.1% | -28.2% | -0.7% | -9.7% |
| SPY | -0.2% | +0.8% | +7.4% | -0.2% | +9.3% |
| vs SPY | -0.5% | -1.9% | -35.6% | -0.5% | -19.1% |